Strengthening cancer control in the South Pacific through coalition-building: a co-design framework

Hyatt, Amelia; Chan, Belinda; Moodie, Rob; Varlow, Megan; Bates, Chris; Foliaki, Sunia; Palafox, Neal A.; Burich, Shelley; Aranda, Sanchia

doi:10.1016/j.lanwpc.2022.100681

Cited by 1 publication

(1 citation statement)

References 34 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Both are Oceania island nations with small populations, geographic dispersion, isolation, limited resources, fragile ecological and economic systems, and overburdened health systems. In addition, patients are usually diagnosed at advanced stages of cancer due to a lack of comprehensive cancer screening, pathology, oncology, surgery, and palliative care facilities [34,35]. As in the previous analysis, other countries and regions with high effective differences were focused in Central Europe, Southern Latin America, and Western Europe.…”

Section: Disease Burden Projectionsmentioning

confidence: 96%

The global, regional, and national testicular cancer burden and trends from 1990 to 2019: results from the Global Burden of Disease Study 2019

Huang,

Li,

Chen

et al. 2023

Preprint

View full text Add to dashboard Cite

Background:To assess the disease burden of Testicular Cancer (TC) from 1990 to 2019. Methods:Global, regional and national age-standardized incidence rate (ASIR), age-standardized prevalence rate (ASPR), age-standardized death rate (ASDR) and age-standardized disability-adjusted life years rate (DALYs) from 1990-2019 were used to analyze the disease burden of TC, combined with decomposition analyses and frontier analyses. Results: The global ADIR, ASPR, ASDR, and age-standardized DALYs in 2019 were 2.79 (2.36,3.33), 21.24 (17.59,25.94), 0.28 (0.26,0.31), and 14.24 (12.91,15.98), respectively. The burden of disease varied by region and country, with Central Europe and Southern Latin America having higher than expected levels. Chile, Tonga, and Monaco were among the countries with a higher disease burden. Decomposition analysis showed population growth as the main factor for changing age-standardized DALYs. Frontier analysis showed that age-standardized DALYs in different countries have much room for improvement, especially in Tonga and Kiribati. The global ADIR, ASPR, ASDR, and age-standardized DALYs are projected to be 3.13, 24.08, 0.29, and 15.01 by 2030. Conclusions: TC remains a global public problem. There are significant regional and national differences, and therefore different regions and countries should be targeted to improve the disease burden of TC.

show abstract

Section: Disease Burden Projectionsmentioning

confidence: 96%